FBIO Fortress Biotech Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: FBIO

Price (delayed)

$2.34

Market cap

$78.04M

P/E Ratio

0.72

Dividend/share

N/A

EPS

$3.26

Enterprise value

-$66.44M

?
Relative Growth: Rel. Growth: 50
Relative Strength: Rel. Strength: 12
Relative Valuation: Rel. Valuation: 92
Relative Profitability: Rel. Profitability: 91

Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty ...

Highlights
FBIO's quick ratio has soared by 136% YoY and by 38% QoQ
The debt has decreased by 23% YoY
Fortress Biotech's EPS has decreased by 15% QoQ
FBIO's net income is down by 12% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.fortressbiotech.com
Peers: VCYT ALKS

Key stats

What are the main financial stats of FBIO

FBIO stock price

How has the Fortress Biotech stock price performed over time
Intraday
-4.49%
1 week
-4.88%
1 month
-18.47%
1 year
-35.89%
YTD
-36.07%
QTD
-23.53%

Financial performance

How have Fortress Biotech's revenue and profit performed over time
Revenue
$68.47M
Gross profit
$44.91M
Operating income
-$29.35M
Net income
$111.82M
Gross margin
65.6%
Net margin
163.3%
FBIO's operating margin has surged by 76% year-on-year and by 49% since the previous quarter
FBIO's operating income has soared by 72% YoY and by 47% from the previous quarter
FBIO's revenue is up by 15% year-on-year and by 3.5% since the previous quarter
The net margin has decreased by 15% QoQ

Price vs fundamentals

How does FBIO's price correlate with its fundamentals

Growth

What is Fortress Biotech's growth rate over time

Valuation

What is Fortress Biotech stock price valuation
P/E
0.72
P/B
0.47
P/S
1.09
EV/EBIT
-0.53
EV/EBITDA
-0.5
EV/Sales
-0.97
Fortress Biotech's EPS has decreased by 15% QoQ
The P/B is 74% less than the 5-year quarterly average of 1.9 and 64% less than the last 4 quarters average of 1.4
The P/S is 24% below the last 4 quarters average of 1.5 and 5% below the 5-year quarterly average of 1.2
FBIO's revenue is up by 15% year-on-year and by 3.5% since the previous quarter

Efficiency

How efficient is Fortress Biotech business performance
The company's return on equity fell by 37% QoQ
The ROA has declined by 26% since the previous quarter
FBIO's return on invested capital is down by 17% since the previous quarter
Fortress Biotech's return on sales has decreased by 15% QoQ

Dividends

What is FBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FBIO.

Financial health

How did Fortress Biotech financials performed over time
The total assets is 186% more than the total liabilities
FBIO's quick ratio has soared by 136% YoY and by 38% QoQ
Fortress Biotech's current ratio has soared by 106% YoY and by 38% from the previous quarter
The debt is 68% lower than the equity
The debt to equity has dropped by 80% year-on-year and by 3% since the previous quarter
The debt has decreased by 23% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.